Chronic Kidney Disease Clinical Trials in Miami, Florida

4 studies are recruiting for chronic kidney disease in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

    This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medicine called empagliflozin helps children and adolescents with CKD. Other goals of the study are to find out how empagliflozin is tolerated and handled by the body in chil…

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    University of Miami, Miami, Florida
    Locations
    93 in total
    Run by
    Boehringer Ingelheim

    See if you can join NCT07107945 on ClinicalTrials.gov

  2. A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

    This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled multicenter study to investigate outcomes with elecoglipron compared with placebo in participants with CKD with and without T2DM who are on background SGLT2i (dapagliflozin) as GDMT and other SoC treatments for CKD.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Research Site, Miami, Florida
    Locations
    715 in total
    Run by
    AstraZeneca

    See if you can join NCT07753993 on ClinicalTrials.gov

  3. Breakthrough - T1DM and Chronic Kidney Disease

    Single arm- subject treated with Tegoprubart and everolimus. The purpose of this research is to gather information on the safety and effectiveness of investigational regimen containing 2 experimental components: * An investigational drug called Tegoprubart and * Human pancreatic islet cells Both Te…

    Stage
    Phase 1
    Ages
    18 to 70
    Site
    Diabetes Research Institute, University of Miami, Miami, Florida
    Locations
    2 in total
    Run by
    University of Chicago

    See if you can join NCT07592000 on ClinicalTrials.gov

  4. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease

    The purpose of this first-in-human (FIH) study is to evaluate safety, tolerability, pharmacokinetic (PK) of OJR520.

    Stage
    Phase 1
    Ages
    18 to 65
    Site
    Quotient Sciences Sea View, Miami, Florida
    Locations
    2 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT07235059 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.